CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-14 | Birchler Brian EVP, Corp and Development Ops | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −11,475 | 12,425 | ||
| 2025-10-06 | Swayze Eric EVP Research | Sale 10b5-1 | −6,849 | $69.02 | $473K | 30,453 |
| 2025-10-06 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +10,200 | $52.87 | $539K | 67,330 |
| 2025-10-06 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −10,200 | $69.89 | $713K | 57,130 |
| 2025-10-06 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −3,241 | $69.27 | $224K | 53,889 |
| 2025-10-06 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −10,200 | 17,000 | ||
| 2025-10-06 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −437 | $69.26 | $30K | 179,572 |
| 2025-10-06 | Baroldi Joseph EVP, Chief Business Officer | Sale 10b5-1 | −1,625 | $69.37 | $113K | 30,301 |
| 2025-10-02 | Swayze Eric EVP Research | Option exercise 10b5-1 | +12,972 | $53.77 | $698K | 50,274 |
| 2025-10-02 | Swayze Eric EVP Research | Sale 10b5-1 | −12,972 | $66.23 | $859K | 37,302 |
| 2025-10-02 | Swayze Eric EVP Research | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −12,972 | 0 | ||
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +30,203 | $56.78 | $1.7M | 87,333 |
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −30,203 | $67.69 | $2.0M | 57,130 |
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise 10b5-1 | +34,461 | $60.89 | $2.1M | 91,591 |
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −34,461 | $67.69 | $2.3M | 57,130 |
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −30,203 | 0 | ||
| 2025-10-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −34,461 | 0 | ||
| 2025-10-02 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +15,000 | $31.80 | $477K | 46,926 |
| 2025-10-02 | Baroldi Joseph EVP, Chief Business Officer | Sale 10b5-1 | −15,000 | $68.01 | $1.0M | 31,926 |
| 2025-10-02 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −15,000 | 26,700 |
Page 22 of 34 · 668 trades